The interactions among these drugs are well researched, but their interaction inside the human body isn’t uniform and varies with the enzymatic protein profile of the liver of an individual. The government-backed data indicates as many as 303 deaths occur per day as a result of drugs. The majority of these deaths, notably, are due to prescription drugs. Drug interaction with liver enzymes isn’t thoroughly explored, but if probed and taken advantage of, it can save a lot of lives and provide ease for those who suffer while healing.

The foundation of Scylex Lab lies in the objective of safer and more efficient patient care through medication safety. Personalised care is sought by every patient and is a basic necessity. To revolutionise patient care, Scylex Lab was founded to collaborate with pharmaceutical companies and evaluate drug interactions using pharmacogenetics, making the drugs safer than ever before for patients.

Scylex Lab was established with a state-of-the-art infrastructure that boasts equipment to perform real-time PCR, generation sequencing, microarrays, and whole genome sequencing to provide a high-resolution, base-by-base view of the entire genome.

Apart from pharmacogenetics, we are highly skilled in providing our clients with pharmaceutical research, biomarker analysis, optimization of novel antibodies, and many more.